Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...

Dr. Alexandra Sowa joins 'Varney & Co.' to discuss weight-loss drugs becoming widely available and RFK Jr.'s push to ban ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

Novo Nordisk’s (NVO) weight-loss drug, which shares an active ingredient with Ozempic, has the highest list price at $1,349.02 per month. In 2024, Eli Lilly started offering single-dose vials ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

The MHRA warns against buying weight-loss medicines illegally, emphasizing health risks and the need for prescriptions from ...